CUE BIOPHARMA INC's ticker is CUE and the CUSIP is 22978P106. A total of 77 filers reported holding CUE BIOPHARMA INC in Q2 2022. The put-call ratio across all filers is 0.29 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $433,946 | -22.4% | 188,672 | +23.2% | 0.00% | – |
Q2 2023 | $559,096 | -6.5% | 153,177 | -8.5% | 0.00% | – |
Q1 2023 | $597,957 | +116.2% | 167,495 | +72.6% | 0.00% | – |
Q4 2022 | $276,547 | +9.3% | 97,034 | -14.5% | 0.00% | – |
Q3 2022 | $253,000 | +289.2% | 113,512 | +331.4% | 0.00% | – |
Q2 2022 | $65,000 | -85.5% | 26,311 | -71.4% | 0.00% | – |
Q1 2022 | $449,000 | -65.5% | 91,901 | -20.1% | 0.00% | – |
Q4 2021 | $1,301,000 | +180.4% | 115,070 | +261.0% | 0.00% | – |
Q3 2021 | $464,000 | +32.6% | 31,877 | +6.1% | 0.00% | – |
Q2 2021 | $350,000 | -35.4% | 30,041 | -32.4% | 0.00% | – |
Q1 2021 | $542,000 | +52.2% | 44,437 | +56.3% | 0.00% | – |
Q4 2020 | $356,000 | -27.5% | 28,427 | -12.9% | 0.00% | – |
Q3 2020 | $491,000 | -40.6% | 32,637 | -3.3% | 0.00% | – |
Q2 2020 | $827,000 | +221.8% | 33,737 | +86.6% | 0.00% | – |
Q1 2020 | $257,000 | +32.5% | 18,084 | +47.7% | 0.00% | – |
Q4 2019 | $194,000 | +74.8% | 12,247 | -6.5% | 0.00% | – |
Q3 2019 | $111,000 | -0.9% | 13,103 | +4.9% | 0.00% | – |
Q2 2019 | $112,000 | +51.4% | 12,493 | +32.0% | 0.00% | – |
Q1 2019 | $74,000 | +7.2% | 9,464 | -35.7% | 0.00% | – |
Q4 2018 | $69,000 | +91.7% | 14,724 | +268.8% | 0.00% | – |
Q3 2018 | $36,000 | -2.7% | 3,992 | +30.8% | 0.00% | – |
Q2 2018 | $37,000 | +311.1% | 3,052 | +361.7% | 0.00% | – |
Q1 2018 | $9,000 | – | 661 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Corriente Advisors, LLC | 1,915,219 | $23,959,000 | 5.70% |
Prosight Management, LP | 906,569 | $11,341,000 | 5.24% |
P.A.W. CAPITAL CORP | 140,000 | $1,751,000 | 1.54% |
Voss Capital, LLC | 220,714 | $2,761,000 | 1.39% |
Robertson Stephens Wealth Management, LLC | 484,000 | $6,054,000 | 1.26% |
Slate Path Capital LP | 1,483,619 | $18,560,000 | 1.00% |
Nantahala Capital Management | 2,506,772 | $31,360,000 | 0.97% |
PRECEPT MANAGEMENT LLC | 150,000 | $1,877,000 | 0.76% |
SANDERS MORRIS HARRIS LLC | 193,591 | $2,449,000 | 0.56% |
Rock Creek Group, LP | 100,014 | $1,251,000 | 0.51% |